Bristol-Myers Squibb (BMY) reported Q3 non-GAAP earnings Thursday of $1.35 per diluted share, down from $1.63 a year earlier. Analysts polled by FactSet expected $1.10. Revenue fo... Oops, something went wrong U.S. markets open in 1h 22m Bristol-Myers Squibb's Q3 Non-GAAP Earnings Decline, Revenue Increases; 2026 Outlook Updated Bristol-Myers…
Bristol Myers Squibb Co. (BMY) released a profit for third quarter that Drops, from the same period last year The company's bottom line totaled $2.162 billion, or $1.05 per share. This compares with $2.201 billion, or $1.08 per share, last year. Excluding items, Bristol…
Oct 29 (Reuters) - Bristol Myers Squibb raised its full-year revenue forecast on Thursday, citing strong sales of its newer medicines, but lowered its 2026 earnings per share projection due to a hefty acquisition-related charge. Wall Street analysts, on average, had forecast full-year…
BRIDGEPORT - Bridgeport High School students exploring careers in the health field got a close look at the work Oct. 19 during a field trip to WVU Medicine Wheeling Hospital. More than 60 students in freshman through senior grades levels attended. Heath science…
Wagner said opening the facility was a career highlight and that he was honored by its dedication, the report notes. Roger Mitty, president of Care New England Medical Group, said the goal is to bring most patients' ambulatory needs to…
Data reinforce the potential for immune reset with zolacabtagene autoleucel to address an underlying cause of multiple sclerosis In the Breakfree-2 study, the majority of adverse events were brief and reversible, generally consistent with previously reported zola-cel Phase 1 clinical trial…
Tempus AI shares rose 6% today after Bristol Myers Squibb agreed to license Tempus's oncology data through 2031 and use its Lens AI platform. Bristol Myers Squibb is a returning customer committing for years, which suggests Tempus's data is the real edge…
Bristol-Myers Squibb (BMY) shares were down 2% after the company said Friday that a patient with highly active relapsing multiple sclerosis in the phase 1 breakfree-2 study evalua... Oops, something went wrong U.S. markets close in 1h 28m Bristol-Myers Squibb Shares Fall After Patient Dealth…
By Muhammad Ali ’27 MPH I had the opportunity to explore these questions firsthand when I attended the 2026 Society for Public Health Education (SOPHE) Advocacy Summit in Washington, D.C., as a student ambassador representing the Connecticut Society for Public Health Education…
During the most recent period, it announced a multibillion-dollar financial investment to establish a multimodal manufacturing campus located in Texas, while also securing an accelerated regulatory approval from the FDA for a combination therapy intended to treat multiple myeloma. Novo…
The systems and their service.
An article joins this feed when it matches these terms. Each one is also a search of its own.